Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-05

FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

The FDA approved a supplemental application for Reyataz (atazanavir) from E.R. Squibb & Sons, L.L.C., updating the labeling as part of an approved supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REYATAZ (atazanavir)

Snippet

SUPPL AP for REYATAZ (ATAZANAVIR)